Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management

Status Completed

Clinical Trial Summary

A pterygium is a fibrovascular growth originating from the conjunctiva that grows onto the surface of the cornea. Frequently, these pterygia will recur even after surgical resection. Bevacizumab is an inhibitor of angiogenesis, which is needed for recurrent growth. The use of bevacizumab is poorly understood in inhibiting pterygium growth. The objective of this study is to compare the effects of wound healing and recurrence rates in postoperative bevacizumab versus pterygium excision alone.

Clinical Trial Description

This is a prospective trial. Thirty-one patients with a primary pterygium of at least 2 mm in size and without any previous ocular surgery will be included. Outcome measures will include best corrected visual acuity, intraocular pressure, recurrence, and any sight threatening complications at two weeks, two months, and six months postoperatively. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Pterygium

Clinical Trial Details

NCT number	NCT01736449
Study type	Interventional
Source	Arrowhead Regional Medical Center
Contact
Status	Completed
Phase	Phase 4
Start date	April 2011
Completion date	April 2012

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02641132` - Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.	Phase 4
Completed	`NCT02342392` - Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study	Phase 2/Phase 3
Recruiting	`NCT01387971` - Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders	N/A
Recruiting	`NCT05978687` - The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision	Phase 4
Not yet recruiting	`NCT06042296` - Expression of CD44, PCNA and E-cadherin in Pterygium Tissue
Completed	`NCT04022811` - Effect of Bromfenac on Pain Related to Pterygium Surgery	Phase 4
Recruiting	`NCT01261455` - Prospective Randomized Pilot Study Comparing Inferior Versus Superior Conjunctival Autografts for Primary Pterygia	N/A
Recruiting	`NCT01249235` - Bandage Contact Lens and Oral Analgesics Versus Patching and Oral Analgesics for Pain Following Pterygium Surgery	N/A
Completed	`NCT01115517` - Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery	Phase 2
Completed	`NCT00768963` - Ranibizumab for the Inhibition of Neovascularization in Pterygia	Phase 1
Completed	`NCT00949728` - Conjunctival Autologous Transplantation Using Fibrin Glue in Primary Pterygia	N/A
Recruiting	`NCT00563277` - Surgical Treatment of Concurrent Cataract and Primary Pterygium	N/A
Completed	`NCT00346450` - Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation	Phase 3
Completed	`NCT03533244` - A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia	Phase 2
Completed	`NCT04403516` - Dextenza in Pterygium Surgery	Phase 4
Recruiting	`NCT02911532` - Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia	N/A
Not yet recruiting	`NCT03304366` - Corneal Changes With Pentacam Before and After Pterygium	N/A
Unknown status	`NCT02015000` - Surgical Result of Pterygium Extended Removal Followed by Fibrin Glue Assisted Amniotic Membrane Transplantation	N/A
Completed	`NCT00344201` - Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of External Eye Surgery	Phase 1
Recruiting	`NCT00326560` - Comparison of Glue With Sutures for Pterygium Surgery	Phase 3